Channelchek - Looking for the next apple? This is the orchard.

ZOMDF

$0.05

(9.3%)

FLWS

$5.1

(0%)

ACCO

$3.72

(-1.33%)

ARLP

$25.75

(-0.81%)

AUIAF

$0.16

(-3.13%)

AZZ

$91.28

(-1.25%)

BTBT

$2.6

(-3.35%)

BTM

$6.25

(-0.48%)

CVKD

$14.99

(-0.07%)

LCE:CA

$0.29

(1.72%)

COCP

$1.54

(-6.1%)

CDRO

$7.48

(-0.13%)

CVGI

$1.43

(-2.72%)

LODE

$3.59

(2.57%)

CMTL

$2.09

(-4.35%)

CNDT

$2.74

(0.37%)

CXW

$21.48

(0.19%)

CMLS

$0.13

(-2.32%)

DRCT

$0.53

(-2.55%)

DLHC

$5.53

(1.28%)

SSP

$2.5

(-7.06%)

ELDN

(0%)

EVC

$2.25

(-5.86%)

EDRY

$8.89

(-2.56%)

ESEA

$43.6

(0.86%)

FAT

$2.65

(0%)

RAIL

$8.9

(0.23%)

GDEV

$22.01

(3.77%)

GOVX

$1.14

(0%)

GOCO

$5.84

(-0.34%)

GHM

$46.99

(2.42%)

GLDD

$11.64

(0.52%)

GYRE

$8.07

(-4.38%)

HMENF

$1.35

(0.15%)

III

$4.78

(-0.83%)

IPOOF

$7.05

(0.86%)

KELYA

$11.98

(-1.4%)

KTOS

$41.24

(2.08%)

LUCK

$8.91

(-0.78%)

MAIA

$1.75

(0%)

MGROF

$0.69

(-4.39%)

NTRB

$7.6

(0%)

OCGN

$1.2

(3.45%)

PERF

$1.82

(-1.09%)

QMCI

$0.16

(0%)

RGP

$5.51

(-0.36%)

SGA

$12.68

(-0.31%)

SHWZ

$0.01

(-25%)

SHIP

$6.81

(-0.29%)

SLQT

$2.24

(-0.88%)

SKYX

$1.23

(0%)

SNAL

$1.25

(-4.56%)

GEO

$26.52

(1.53%)

ODP

$18.11

(-0.39%)

TNXP

$34.54

(-8.41%)

TSQ

$7.01

(0.14%)

TZOO

$12.88

(-2.72%)

UNCY

$0.64

(1.27%)

VVX

$45.25

(0.89%)

VNCE

$1.48

(4.23%)

XELB

$1.89

(0.53%)

ZOMDF

$0.05

(9.3%)

FLWS

$5.1

(0%)

channelchek-in

‌

6/12/2025

BioNTech to Acquire CureVac in Strategic All-Stock Deal to Accelerate Cancer Immunotherapy Innovation

In a major step forward for the future of mRNA-based medicine, BioNTech SE has announced it will acquire fellow German biotech firm CureVac N.V. in an all-stock deal valued at approximately $1.25 billion. The transaction is set to bolster BioNTech’s capabilities in cancer immunotherapy and mRNA research, positioning the company for deeper innovation and broader commercialization in oncology.

3 min read